Vertex Pharmaceuticals | search
Click here to view Vertex Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Vertex Pharmaceuticals | Our Science | R&D PipelineVertex Pharmaceuticals is focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives.
- Investor Relations | Vertex PharmaceuticalsThe Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
- Vertex Reports Third Quarter 2024 Financial ResultsBOSTON--(BUSINESS WIRE)--Nov. 4, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year product revenue guidance to $10.8 billion to $10.9 billion.
- Vertex Pharmaceuticals | Our CompanyVertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
- Vertex Pharmaceuticals | Our CompanyVertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
More
